Back to search

Netherlands· NL-70ea3ab94112

Exluton, tabletten 0,5 mg

A lynestrenol product containing lynestrenol, registered in Netherlands by N.V. Organon (Kloosterstraat 6). The same ATC class is registered in 2 of our 19 countries.

ATC G03AC02

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedExluton, tabletten 0,5 mgATCG03AC02REGISTER NO.NL-70ea3ab94112PACKS LISTED1CHECKEDSeptember 29, 2026

Where it is registered

Lynestrenol is registered in 2 of 19 countries.

Countries holding a registration under ATC G03AC02 (lynestrenol), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 1 of them publish a price we can compare per daily dose

Lynestrenol · ATC G03AC02

2 / 19 countries

  • Finlandprice
  • Netherlands
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

CBG-MEB (Netherlands)
Active substance
LYNESTRENOL
Manufacturer
N.V. Organon (Kloosterstraat 6)
Country
Netherlands (NL)
ATC code
G03AC02
ATC class
Lynestrenol
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    06443

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Lynestrenol in 5 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All lynestrenol products

Authorised across Europe · EMA

The same active substance is authorised in 7 EEA countries. Names it is sold under:

  • Austria · Orgametril
  • Belgium · Orgametril
  • Czechia · Orgametril
  • Finland · Orgametril
  • Luxembourg · Orgametril
  • Poland · Orgametril
  • Sweden · Exlutena

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/bb6609ea-3e80-467a-ba8d-be247411896e
GET /v1/drugs/bb6609ea-3e80-467a-ba8d-be247411896e?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tablet",
  "route": "Oraal gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h06443_smpc.pdf",
  "strength": null,
  "atc_label": "Lynestrenol",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg06443",
  "excipients": [
    "AMYLOPECTIN (RI)",
    "LACTOSE 1-WATER",
    "MAGNESIUMSTEARAAT (E 470b)",
    "POTATO STARCH (RI)"
  ],
  "substances": [
    "LYNESTRENOL"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h06443.pdf",
  "authorised_at": "1972/04/26",
  "procedure_number": null,
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "06443",
  "additional_monitoring": "N"
}

See everything about lynestrenol.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.